InvestorsHub Logo
Followers 8
Posts 1427
Boards Moderated 0
Alias Born 06/30/2016

Re: doogdilinger post# 33601

Friday, 03/16/2018 2:08:42 PM

Friday, March 16, 2018 2:08:42 PM

Post# of 38634
Doog, your findings were accurate. what you copied and pasted earlier is from the latest filing. It appears the company is now back peddling on any advance of Regabatin.

For our RegabatinTM XR 505(b)(2) product candidate, Phase III clinical trials can be capital intensive, and will only be undertaken consistent with the availability of funds and a prudent cash management strategy



This is different from their previous indication of intending to start phase 3 trails by year end.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y